Dyne Therapeutics, Inc.
DYN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,218,033 | $793,795 | $602,406 | $605,142 |
| - Cash | $435,449 | $121,626 | $172,147 | $200,825 |
| + Debt | $23,988 | $27,415 | $30,483 | $32,636 |
| Enterprise Value | $1,806,572 | $699,584 | $460,742 | $436,953 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$2,243 | -$2,461 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$315,175 | -$233,476 | -$169,279 | -$148,937 |
| % Margin | – | – | – | – |
| Net Income | -$317,418 | -$235,937 | -$168,099 | -$149,291 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.37 | -3.95 | -3.23 | -2.93 |
| % Growth | 14.7% | -22.3% | -10.2% | – |
| Operating Cash Flow | -$292,369 | -$188,158 | -$153,645 | -$119,563 |
| Capital Expenditures | -$2,376 | -$729 | -$3,067 | -$3,618 |
| Free Cash Flow | -$294,745 | -$188,887 | -$156,712 | -$123,181 |